On November 5, 2020, Denovicon Therapeutics Founder & CEO, Scott Bembenek, took part in the Lab of the Future panel entitled ‘Strategies for Accelerating Drug Discovery with AI.’
On July 14, 2020, Denovicon Therapeutics Founder & CEO, Scott Bembenek, shared some of his experiences and insights from his scientific and entrepreneurial journeys (thus far) with Rady and UCSD students at Rady’s Careers in Biotech Panel.
As part of Denovicon Therapeutics’ commitment to COVID-19, we tasked our novel molecular modeling-artificial intelligence (AI) hybrid computational platform to find potential therapies from over 13,000 FDA-approved drugs and clinical candidates. The molecular modeling...